Soni Manmeet Singh 4
4 · Summit Therapeutics Inc. · Filed Aug 23, 2024
Insider Transaction Report
Form 4
Soni Manmeet Singh
DirectorCOO and CFO
Transactions
- Award
Performance Stock Option (right to buy)
2024-08-23+2,800,000→ 2,800,000 totalExercise: $1.68Exp: 2033-10-13→ Common Stock (2,800,000 underlying)
Footnotes (2)
- [F1]These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 11,200,000 shares underlying options which were granted on October 13, 2023 that remain subject to the satisfaction of performance conditions.
- [F2]Not applicable.